Skip to content

Fetal Renal Artery Doppler in Patients With Preeclampsia

Fetal Renal Artery Doppler and Three Dimensional Power Doppler Study of Placenta in Patients With Preeclampsia and Its Role in Prediction of Adverse Neonatal Outcomes

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06395974
Enrollment
114
Registered
2024-05-02
Start date
2024-11-01
Completion date
2026-02-15
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preeclampsia

Brief summary

Preeclampsia is a major devastating disorder affects 2:10% of pregnancies worldwide. preeclampsia may be associated with placental insufficiency which may cause fetal blood redistribution to essential organs like brain, heart, kidney.

Detailed description

Preeclampsia is a major devastating medical condition that affects pregnant women after 20 weeks of pregnancy. It affects 2:10% of pregnancies worldwide according to World Health Organisation with higher incidence in developing countries. Vascular endothelial dysfunction due to abnormal placentation is believed to be the main cause of multi-organ failure and uteroplacental insufficiency that occur in preeclampsia leading to major adverse effects in both mother and fetus. Placental insufficiency causes a redistribution of fetal blood to essential organs ; brain, heart and adrenal glands by decreasing their vascular resistance on expense of peripheral organs. Changes occur in fetal renal circulation in preeclampsia is still area of debate with conflicting results in literature. Doppler ultrasound examination of vasculature of selected organs such as kidneys may have a role in detection of hemodynamic rearrangements that occur in cases of placental insufficiency and preeclampsia. Also, Three dimensional power Doppler plays a role in comprehensive analysis of placental perfusion. It has a promising results regarding prediction of preeclampsia during early pregnancy and may have insights into prediction of adverse neonatal outcomes in late trimester.

Interventions

OTHERfetal ultrasound

2D, 3D , Doppler ultrasound

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* a) Preeclampsia: * Women with preeclampsia \>28 weeks of pregnancy. * Singleton pregnancy. * Women with intrauterine growth restriction and abnormal amniotic fluid volume to simulate real world data. b) Control: * Women with healthy pregnancy matched by closest gestational age.

Exclusion criteria

* ● Multiple pregnancy. * Known Congenital fetal malformations. * Women with other comorbidity such as ischemic heart disease, DM, Autoimmune disorders, kidney disease, neurological disorders, liver or haematological disorders. * Women unable to provide informed consent. * Women who refuse to participate

Design outcomes

Primary

MeasureTime frameDescription
fetal renal artery doppler indices1 yearthe difference between the Fetal renal artery Doppler indices between preeclamptic patients and women with healthy pregnancy
Middle cerberal artery doppler indices , Umbilical artery doppler indices and placental volume1 year

Secondary

MeasureTime frameDescription
neonatal outcome1 yearthe ability of Fetal renal artery Doppler in prediction of neonatal complications.

Countries

Egypt

Contacts

PRINCIPAL_INVESTIGATORYousra O Mokhtar

principle investigator

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 12, 2026